Asthma  >>  Riarify (beclometasone/formoterol/glycopyrrolate)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Riarify (beclometasone/formoterol/glycopyrrolate) / Chiesi
2019-002238-35: Open label, non-randomized, single dose PK/PD study in adolescent asthmatic patients and adult asthmatic patients

Not yet recruiting
2
80
Europe
CHF 5993 pMDI, Pressurised inhalation, solution, Trimbow
Chiesi Farmaceutici S.p.A., Chiesi Farmaeutici S.p.A.
asthma, asthma, Diseases [C] - Respiratory Tract Diseases [C08]
 
 

Download Options